Fourth quarter ended December 31, 2022 revenue up 55% versus the prior year to $38.1 million; calendar year ended December 31, 2022 revenue up 118% versus the prior year period to $146.1 million Short Distance revenue up 51% in Q4 2022 versus the prior year period, reflecting higher pricing across our route network and our acquisitions of Blade Europe and Blade Canada MediMobility Organ Transport revenue up 120% in Q4 2022... Read More